Novocure Announces Favorable Recommendation to Continue the Phase 3 Pivotal INNOVATE-3 Study of Tumor Treating Fields in Ovarian CancerBusiness Wire • 03/23/22
Novocure Founder Yoram Palti Wins 2022 Israel Prize in Entrepreneurship and Technological InnovationBusiness Wire • 02/28/22
NovoCure's (NVCR) CEO Asaf Danziger on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/24/22
Novocure Q4 Earnings Miss Street View, New Data Shows TTFields Initiates Downstream Anti-Tumor ResponseBenzinga • 02/24/22
New Data Finds Tumor Treating Fields Initiates Downstream Anti-Tumor ResponseBusiness Wire • 02/24/22
Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company UpdateBusiness Wire • 02/24/22
Novocure Announces Preliminary Full Year and Fourth Quarter 2021 Net Revenues and Provides Company UpdateBusiness Wire • 01/10/22
Novocure Signs Agreement to Acquire and Construct Building in Downtown Portsmouth, New HampshireBusiness Wire • 12/07/21
Novocure Announces 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research ProgramBusiness Wire • 12/06/21